Michael Calvo is named as a lobbyist on federal disclosure filings for 2 clients through Bristol-myers Squibb Company and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code and Copyright/Patent/Trademark.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY | Q3 2026 | Trade (domestic/foreign), Taxation/Internal Revenue Code, Medicare/Medicaid |
| BRIDGEBIO PHARMA, INC. | BRIDGEBIO PHARMA, INC. | Q3 2025 | Pharmacy |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 2 | 2 |
| Year | Items | Total |
|---|---|---|
| 2025 | 3 | $2K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Michael Calvo. See the Capitol Clarity rankings and method.